ВИЧ и СПИД - Тестирование и диагностика
Вопросы
В обработке
Ответ предоставлен
Номер |
Вопрос |
Тема |
Ответ |
| 324 |
|
Эффективность терапии |
|
| 1473 |
|
Эффективная профилактика передозировки |
|
| 683 |
|
эпид.надзор |
|
| 557 |
|
Экспресс-тест |
|
| 1196 |
|
Что такое ИБ? |
|
Общее количество 323 ( Далее )
Публикации
Обращение |
Авторы |
Публикация |
Страница(ы) | Ссылка / Файл | |
|---|---|---|---|---|---|
| US Department of Health and Human Services Guidelines |
:
|
||||
| The answer is provided by deputy director of AIDS RC E.Bakiev | |||||
| More Evidence of Rapid Liver Disease Progression in HIV/HCV Coinfected People, but Antiretroviral Therapy Lowers Risk |
:
|
||||
| Human immunodeficiency virus type 2 | Centers for Disease Control and Prevention | N/A |
:
:
|
||
| n as AIDS, researchers discovered the primary causative viral agent, the human immunodeficiency virus type 1 (HIV-1). In 1986, a second type of HIV, called HIV-2, was isolated from AIDS patients in West Africa, where it may have been present decades earlier. Studies of the natural history of HIV-2 are limited, but to date comparisons with HIV-1 show some similarities while suggesting differences. Both HIV-1 and HIV-2 have the same modes of transmission and are associated with similar opportunistic infections and AIDS. In persons infected with HIV-2, immunodeficiency seems to develop more slowly and to be milder. Compared with persons infected with HIV-1, those with HIV-2 are less infectious early in the course of infection. As the disease advances, HIV-2 infectiousness seems to increase; however, compared with HIV-1, the duration of this increased infectiousness is shorter. HIV-1 and HIV-2 also differ in geographic patterns of infection; the United States has few reported cases. | |||||
| HIV Testing and Pregnancy | AIDSinfo - http://aidsinfo.nih.gov |
:
|
|||
Общее количество 6 ( Далее )




